About

The program on Designing Nanoparticles for Targeted Cancer Therapy provides researchers, scientists, and healthcare professionals with in-depth knowledge and practical skills in nanoparticle-based cancer therapy. It covers the latest advancements, strategies, and challenges in designing nanoparticles for targeted drug delivery to cancer cells.

Aim

The aim of the program is to provide a comprehensive understanding of the principles, techniques, and advancements in designing nanoparticles specifically tailored for targeted cancer therapy.

Program Objectives

• Explore Nanoparticle Design and Engineering
• Examine Drug Loading and Release Mechanisms
• Characterize Nanoparticle Properties
• Improve the Pharmacokinetics
• Reduce the Systemic Toxicities of Chemotherapies

Program Structure

• Module 1: Principles and Designing of Targeted drug-delivery systems (TDDS) for Cancer Therapy
• Module 2: Physicochemical characterization, Biocompatibility and Applications of TDDS for Cancer Therapy
• Module 3: TDDS in the Market, Various Stages of Clinical Translation and Regulatory Aspects

Participant’s Eligibility

Undergraduate degree in Chemistry, Biology, Pharmacy, or related fields. Professionals in pharmaceuticals, biotechnology, or healthcare sectors. Individuals with a background in materials science or medicinal chemistry interested in oncology.

Program Outcomes

• Enhanced understanding of cancer biology and oncogenic signaling pathways.
• Familiarity with different cancer treatment modalities.
• Knowledge of nanotechnology applications in cancer therapy.
• Awareness of drug resistance mechanisms in cancer.
• Understanding of tumor targeting strategies.